These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4087260)

  • 1. Sjögren's syndrome: treatment with D-penicillamine and hydroxychloroquine.
    Lakhanpal S; Duffy J; Griffing WL; Conn DL; Luthra HS
    J Rheumatol; 1985 Oct; 12(5):1028-9. PubMed ID: 4087260
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of primary Sjögren's syndrome with D-penicillamine: a pilot study.
    ter Borg EJ; Haanen HC; Haas FJ; Bistervels JH; Huisman FW; Kerckhaert JA; Kallenberg CG
    Neth J Med; 2002 Nov; 60(10):402-6. PubMed ID: 12607591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary Gougerot-Sjögren syndrome. Favourable effect of a fundamental treatment with hydroxychloroquine on biological anomalies].
    Chaouat D; Aron Rosa D; Aron B
    Rev Rhum Mal Osteoartic; 1988 Oct; 55(10):797-8. PubMed ID: 3194698
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary Gougerot-Sjögren syndrome with necrotizing polymyositis: favorable effect of hydroxychloroquine].
    Ponge T; Mussini JM; Ponge A; Forgeau Y; Barrier J; Cottin S; Grolleau JY
    Rev Neurol (Paris); 1987; 143(2):147-8. PubMed ID: 3602794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition and management of Sjögren's syndrome: strategies for the advanced practice nurse.
    Vale DL
    Nurs Clin North Am; 2000 Mar; 35(1):267-78. PubMed ID: 10673580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of primary Sjögren's syndrome with hydroxychloroquine: a retrospective, open-label study.
    Fox RI; Dixon R; Guarrasi V; Krubel S
    Lupus; 1996 Jun; 5 Suppl 1():S31-6. PubMed ID: 8803908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Subclavian steal syndrome associated with Sjögren's syndrome].
    Machtey I
    Harefuah; 1973 Aug; 85(4):174-6. PubMed ID: 4756189
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic vasculitis developing after hydroxychloroquine interruption in a patient with Sjögren's syndrome.
    Okan G; Karaaslan M; Büyükbabani N
    Clin Exp Dermatol; 2010 Jun; 35(4):442-3. PubMed ID: 19886967
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrent psoriatic onychoperiostitis induced by hydroxychloroquine.
    Sibilia J; Cribier B; Javier RM; Pflumio F; Kuntz JL
    Rev Rhum Engl Ed; 1995 Dec; 62(11):795-7. PubMed ID: 8869222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Articular manifestations in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients.
    Fauchais AL; Ouattara B; Gondran G; Lalloué F; Petit D; Ly K; Lambert M; Launay D; Loustaud-Ratti V; Bezanahari H; Liozon E; Hachulla E; Jauberteau MO; Vidal E; Hatron PY
    Rheumatology (Oxford); 2010 Jun; 49(6):1164-72. PubMed ID: 20299380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
    Rihl M; Ulbricht K; Schmidt RE; Witte T
    Rheumatology (Oxford); 2009 Jul; 48(7):796-9. PubMed ID: 19433433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychloroquine therapy in patients with primary Sjögren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase.
    Dawson LJ; Caulfield VL; Stanbury JB; Field AE; Christmas SE; Smith PM
    Rheumatology (Oxford); 2005 Apr; 44(4):449-55. PubMed ID: 15590764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year double blind crossover trial.
    Kruize AA; Hené RJ; Kallenberg CG; van Bijsterveld OP; van der Heide A; Kater L; Bijlsma JW
    Ann Rheum Dis; 1993 May; 52(5):360-4. PubMed ID: 8323383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the clinical efficacy of yiqi fumai injection combined hydroxychloroquine sulfate tablet for treating Sjogren's syndrome].
    Chen FY; Xue B; Wang H
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Dec; 32(12):1621-3. PubMed ID: 23469599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-penicillamine treatment for chronic sensory ataxic neuropathy associated with Sjögren's syndrome.
    Asahina M; Kuwabara S; Asahina M; Nakajima M; Hattori T
    Neurology; 1998 Nov; 51(5):1451-3. PubMed ID: 9818879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hydroxychloroquine on salivary flow rates and oral complaints of Sjögren patients: a prospective sample study.
    Cankaya H; Alpöz E; Karabulut G; Güneri P; Boyacioglu H; Kabasakal Y
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jul; 110(1):62-7. PubMed ID: 20610299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of patients presenting with Sjogren's syndrome.
    Venables PJ
    Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):791-807. PubMed ID: 16979538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombopenia secondary to hydroxychloroquine].
    Caminal Montero L; González Marroquín A; Ferro Mosquera J; Susano R
    An Med Interna; 1994 Jun; 11(6):310. PubMed ID: 7918951
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of primary Sjögren's syndrome with hydroxychloroquine.
    Fox RI; Chan E; Benton L; Fong S; Friedlaender M; Howell FV
    Am J Med; 1988 Oct; 85(4A):62-7. PubMed ID: 3177432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Sjögren's syndrome by delagil.
    Deseö E
    Ther Hung; 1968; 16(2):74-7. PubMed ID: 5666418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.